Literature DB >> 24327207

Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.

Yee-Ki Lee1, Philip Wing-Lok Ho, Revital Schick, Yee-Man Lau, Wing-Hon Lai, Ting Zhou, Yanhua Li, Kwong-Man Ng, Shu-Leung Ho, Miguel Angel Esteban, Ofer Binah, Hung-Fat Tse, Chung-Wah Siu.   

Abstract

Friedreich ataxia (FRDA), a recessive neurodegenerative disorder commonly associated with hypertrophic cardiomyopathy, is due to GAA repeat expansions within the first intron of the frataxin (FXN) gene encoding the mitochondrial protein involved in iron-sulfur cluster biosynthesis. The triplet codon repeats lead to heterochromatin-mediated gene silencing and loss of frataxin. Nevertheless, inadequacy of existing FRDA-cardiac cellular models limited cardiomyopathy studies. We tested the hypothesis that iron homeostasis deregulation accelerates reduction in energy synthesis dynamics which contributes to impaired cardiac calcium homeostasis and contractile force. Silencing of FXN expressions occurred both in somatic FRDA-skin fibroblasts and two of the induced pluripotent stem cells (iPSC) clones; a sign of stress condition was shown in FRDA-iPSC cardiomyocytes with disorganized mitochondrial network and mitochondrial DNA (mtDNA) depletion; hypertrophic cardiac stress responses were observed by an increase in α-actinin-positive cell sizes revealed by FACS analysis as well as elevation in brain natriuretic peptide (BNP) gene expression; the intracellular iron accumulated in FRDA cardiomyocytes might be due to attenuated negative feedback response of transferring receptor (TSFR) expression and positive feedback response of ferritin (FTH1); energy synthesis dynamics, in terms of ATP production rate, was impaired in FRDA-iPSC cardiomyocytes, which were prone to iron overload condition. Energetic insufficiency determined slower Ca(2+) transients by retarding calcium reuptake to sarcoplasmic reticulum (SR) and impaired the positive inotropic and chronotropic responses to adrenergic stimulation. Our data showed for the first time that FRDA-iPSCs cardiac derivatives represent promising models to study cardiac stress response due to impaired iron homeostasis condition and mitochondrial damages. The cardiomyopathy phenotype was accelerated in an iron-overloaded condition early in calcium homeostasis aspect.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24327207     DOI: 10.1007/s00424-013-1414-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  35 in total

1.  Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia.

Authors:  G Geoffroy; A Barbeau; G Breton; B Lemieux; M Aube; C Leger; J P Bouchard
Journal:  Can J Neurol Sci       Date:  1976-11       Impact factor: 2.104

2.  Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.

Authors:  Jun Liu; Paul J Verma; Marguerite V Evans-Galea; Martin B Delatycki; Anna Michalska; Jessie Leung; Duncan Crombie; Joseph P Sarsero; Robert Williamson; Mirella Dottori; Alice Pébay
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 3.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

4.  Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.

Authors:  Qizhou Lian; Yuelin Zhang; Jinqiu Zhang; Hua Kun Zhang; Xingang Wu; Yang Zhang; Francis Fu-Yuen Lam; Sarang Kang; Jian Chuan Xia; Wing-Hong Lai; Ka-Wing Au; Yen Yen Chow; Chung-Wah Siu; Chuen-Neng Lee; Hung-Fat Tse
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

5.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

6.  Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues.

Authors:  Alain Martelli; Marie Wattenhofer-Donzé; Stéphane Schmucker; Samuel Bouvet; Laurence Reutenauer; Hélène Puccio
Journal:  Hum Mol Genet       Date:  2007-06-27       Impact factor: 6.150

Review 7.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

8.  The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.

Authors:  Alaina Kipps; Mark Alexander; Steven D Colan; Kimberlee Gauvreau; Leslie Smoot; Lisa Crawford; Basil T Darras; Elizabeth D Blume
Journal:  Pediatr Cardiol       Date:  2008-08-21       Impact factor: 1.655

9.  Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.

Authors:  Michael Bunse; Nana Bit-Avragim; Axel Riefflin; Andreas Perrot; Oliver Schmidt; Friedmar R Kreuz; Rainer Dietz; Wulf-Ingo Jung; Karl Josef Osterziel
Journal:  Ann Neurol       Date:  2003-01       Impact factor: 10.422

10.  The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases.

Authors:  J B Lamarche; M Côté; B Lemieux
Journal:  Can J Neurol Sci       Date:  1980-11       Impact factor: 2.104

View more
  19 in total

Review 1.  Modeling simple repeat expansion diseases with iPSC technology.

Authors:  Edyta Jaworska; Emilia Kozlowska; Pawel M Switonski; Wlodzimierz J Krzyzosiak
Journal:  Cell Mol Life Sci       Date:  2016-06-03       Impact factor: 9.261

Review 2.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

Review 3.  Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.

Authors:  Michelle J Doyle; Jamie L Lohr; Christopher S Chapman; Naoko Koyano-Nakagawa; Mary G Garry; Daniel J Garry
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

Review 4.  Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

Authors:  Alain van Mil; Geerthe Margriet Balk; Klaus Neef; Jan Willem Buikema; Folkert W Asselbergs; Sean M Wu; Pieter A Doevendans; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2018-12-01       Impact factor: 10.787

5.  Progress in understanding Friedreich's ataxia using human induced pluripotent stem cells.

Authors:  Anna M Schreiber; Julia O Misiorek; Jill S Napierala; Marek Napierala
Journal:  Expert Opin Orphan Drugs       Date:  2019-01-09       Impact factor: 0.694

6.  Prospects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes.

Authors:  Jonas Schwan; Stuart G Campbell
Journal:  Biomark Insights       Date:  2015-06-10

7.  Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.

Authors:  Ioannis Karakikes; Francesca Stillitano; Mathieu Nonnenmacher; Christos Tzimas; Despina Sanoudou; Vittavat Termglinchan; Chi-Wing Kong; Stephanie Rushing; Jens Hansen; Delaine Ceholski; Fotis Kolokathis; Dimitrios Kremastinos; Alexandros Katoulis; Lihuan Ren; Ninette Cohen; Johannes M I H Gho; Dimitrios Tsiapras; Aryan Vink; Joseph C Wu; Folkert W Asselbergs; Ronald A Li; Jean-Sebastien Hulot; Evangelia G Kranias; Roger J Hajjar
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

Review 8.  Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.

Authors:  Atsushi Tanaka; Shinsuke Yuasa; Koichi Node; Keiichi Fukuda
Journal:  Int J Mol Sci       Date:  2015-08-12       Impact factor: 5.923

Review 9.  Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.

Authors:  Thomas Eschenhagen; Christine Mummery; Bjorn C Knollmann
Journal:  Cardiovasc Res       Date:  2015-01-24       Impact factor: 10.787

Review 10.  Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells.

Authors:  Kwong-Man Ng; Cheuk-Yiu Law; Hung-Fat Tse
Journal:  J Clin Med       Date:  2014-10-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.